Bio-Path Holdings (BPTH) is scheduled to report Q4 earnings on April 28, 2026.
Bio-Path Holdings has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Bio-Path Holdings has averaged an EPS surprise of 0.39% and a revenue surprise of 0.00%.
Analyze the earnings history of Bio-Path Holdings using advanced sorting and filters.
The chart below shows Bio-Path Holdings's reported EPS compared to analyst estimates over recent quarters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $-0.55 | $-0.40 | -37.5 % |
| Q1 | 2025-05-15 | $-0.40 | $-0.38 | -5.26 % |
| Q4 | 2025-03-27 | $-0.07 | $-0.37 | 81.1 % |
| Q3 | 2024-11-15 | $-0.70 | $-1.02 | 31.4 % |
The chart below shows Bio-Path Holdings's reported revenue compared to analyst estimates over recent quarters.
Bio-Path Holdings (BPTH) is scheduled to report earnings on May 14, 2026. The last reported earnings were for reported on January 13, 2026 for Q3.
The Actual EPS was $-0.11, which missed the estimate of $0.00.
The Actual Revenue was $0.00, which hit the estimate of $0.00.